{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:24:59Z","timestamp":1722731099050},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,3]]},"DOI":"10.7759\/cureus.66088","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T17:16:35Z","timestamp":1722705395000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinicohistopathological Correlation and Prognostic Significance of Molecular Biomarkers in Urinary Bladder Neoplasms: A Comprehensive Analysis"],"prefix":"10.7759","author":[{"given":"Avinash","family":"Mane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanda J","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul B","family":"Hulwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishek","family":"Koley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10040100","article-title":"Bladder cancer: new insights into its molecular pathology","volume":"10","author":"Inamura K","year":"2018","unstructured":"Inamura K. Bladder cancer: new insights into its molecular pathology. Cancers (Basel). 2018, 10:100. 10.3390\/cancers10040100","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12101745","article-title":"Advanced bladder cancer: changing the treatment landscape","volume":"12","author":"Bilim V","year":"2022","unstructured":"Bilim V, Kuroki H, Shirono Y, Murata M, Hiruma K, Tomita Y. Advanced bladder cancer: changing the treatment landscape. J Pers Med. 2022, 12:1745. 10.3390\/jpm12101745","journal-title":"J Pers Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch J","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina (Kaunas). 2021, 57:749. 10.3390\/medicina57080749","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08689-7","article-title":"Molecular classification of urothelial bladder carcinoma","volume":"50","author":"Schwarzova L","year":"2023","unstructured":"Schwarzova L, Varchulova Novakova Z, Danisovic L, Ziaran S. Molecular classification of urothelial bladder carcinoma. Mol Biol Rep. 2023, 50:7867-77. 10.1007\/s11033-023-08689-7","journal-title":"Mol Biol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyu219","article-title":"Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?","volume":"45","author":"Kitamura H","year":"2015","unstructured":"Kitamura H, Kakehi Y. Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?. Jpn J Clin Oncol. 2015, 45:315-22. 10.1093\/jjco\/hyu219","journal-title":"Jpn J Clin Oncol"},{"key":"ref6","article-title":"Non-muscle-invasive bladder cancer: overview and contemporary treatment landscape of neoadjuvant chemoablative therapies","volume":"22","author":"Matulewicz RS","year":"2020","unstructured":"Matulewicz RS, Steinberg GD. Non-muscle-invasive bladder cancer: overview and contemporary treatment landscape of neoadjuvant chemoablative therapies. Rev Urol. 2020, 22:43-51.","journal-title":"Rev Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97500-3","article-title":"Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer","volume":"11","author":"Eckstein M","year":"2021","unstructured":"Eckstein M, Kimmel C, Bruendl J, et al.. Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer. Sci Rep. 2021, 11:17981. 10.1038\/s41598-021-97500-3","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2014.06.001","article-title":"Multimodal management of muscle-invasive bladder cancer","volume":"38","author":"Park JC","year":"2014","unstructured":"Park JC, Citrin DE, Agarwal PK, Apolo AB. Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014, 38:80-108. 10.1016\/j.currproblcancer.2014.06.001","journal-title":"Curr Probl Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala K","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020, 8:15. 10.3390\/medsci8010015","journal-title":"Med Sci (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuro.2013.01.001","article-title":"Constitutional and occupational risk factors associated with bladder cancer","volume":"37","author":"Ferr\u00eds J","year":"2013","unstructured":"Ferr\u00eds J, Garcia J, Berbel O, Ortega JA. Constitutional and occupational risk factors associated with bladder cancer. Actas Urol Esp. 2013, 37:513-22. 10.1016\/j.acuro.2013.01.001","journal-title":"Actas Urol Esp"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/or.2023.10603","article-title":"Genetic polymorphisms involved in bladder cancer: a global review","volume":"17","author":"Kourie HR","year":"2023","unstructured":"Kourie HR, Zouein J, Succar B, et al.. Genetic polymorphisms involved in bladder cancer: a global review. Oncol Rev. 2023, 17:10603. 10.3389\/or.2023.10603","journal-title":"Oncol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5213\/inj.1632752.376","article-title":"Genetic and epigenetic alterations in bladder cancer","volume":"20","author":"Li HT","year":"2016","unstructured":"Li HT, Duymich CE, Weisenberger DJ, Liang G. Genetic and epigenetic alterations in bladder cancer. Int Neurourol J. 2016, 20:S84-94. 10.5213\/inj.1632752.376","journal-title":"Int Neurourol J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/s24010037","article-title":"Biomarkers in cancer detection, diagnosis, and prognosis","volume":"24","author":"Das S","year":"2023","unstructured":"Das S, Dey MK, Devireddy R, Gartia MR. Biomarkers in cancer detection, diagnosis, and prognosis. Sensors (Basel). 2023, 24:37. 10.3390\/s24010037","journal-title":"Sensors (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100661","article-title":"Non-urothelial and urothelial variants of bladder cancer","volume":"33","author":"Yu EM","year":"2022","unstructured":"Yu EM, Belay S, Li W, Aragon-Ching JB. Non-urothelial and urothelial variants of bladder cancer. Cancer Treat Res Commun. 2022, 33:100661. 10.1016\/j.ctarc.2022.100661","journal-title":"Cancer Treat Res Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/tau-22-43","article-title":"Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes","volume":"11","author":"Ogbue O","year":"2022","unstructured":"Ogbue O, Haddad A, Almassi N, Lapinski J, Daw H. Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes. Transl Androl Urol. 2022, 11:877-901. 10.21037\/tau-22-43","journal-title":"Transl Androl Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman ND","year":"2011","unstructured":"Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011, 306:737-45. 10.1001\/jama.2011.1142","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2020.3098","article-title":"Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence","volume":"64","author":"Ziaran S","year":"2020","unstructured":"Ziaran S, Harsanyi S, Bevizova K, et al.. Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence. Eur J Histochem. 2020, 64:3098. 10.4081\/ejh.2020.3098","journal-title":"Eur J Histochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00625-7","article-title":"Role of tyrosine kinases in bladder cancer progression: an overview","volume":"18","author":"Zangouei AS","year":"2020","unstructured":"Zangouei AS, Barjasteh AH, Rahimi HR, Mojarrad M, Moghbeli M. Role of tyrosine kinases in bladder cancer progression: an overview. Cell Commun Signal. 2020, 18:127. 10.1186\/s12964-020-00625-7","journal-title":"Cell Commun Signal"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-1243","article-title":"The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma","volume":"9","author":"Kang HW","year":"2020","unstructured":"Kang HW, Kim WJ, Yun SJ. The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma. Transl Cancer Res. 2020, 9:6609-23. 10.21037\/tcr-20-1243","journal-title":"Transl Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8205836","article-title":"Molecular biomarkers in bladder cancer: novel potential indicators of prognosis and treatment outcomes","volume":"2016","author":"Nagata M","year":"2016","unstructured":"Nagata M, Muto S, Horie S. Molecular biomarkers in bladder cancer: novel potential indicators of prognosis and treatment outcomes. Dis Markers. 2016, 2016:8205836. 10.1155\/2016\/8205836","journal-title":"Dis Markers"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1114203","article-title":"Identifying novel biomarkers associated with bladder cancer treatment outcomes","volume":"13","author":"Castaneda PR","year":"2023","unstructured":"Castaneda PR, Theodorescu D, Rosser CJ, Ahdoot M. Identifying novel biomarkers associated with bladder cancer treatment outcomes. Front Oncol. 2023, 13:1114203. 10.3389\/fonc.2023.1114203","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263111-clinicohistopathological-correlation-and-prognostic-significance-of-molecular-biomarkers-in-urinary-bladder-neoplasms-a-comprehensive-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T17:16:38Z","timestamp":1722705398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263111-clinicohistopathological-correlation-and-prognostic-significance-of-molecular-biomarkers-in-urinary-bladder-neoplasms-a-comprehensive-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.66088","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,3]]}}}